FREESTYLE LIBRE Trademark

Trademark Overview


On Friday, April 28, 2017, a trademark application was filed for FREESTYLE LIBRE with the United States Patent and Trademark Office. The USPTO has given the FREESTYLE LIBRE trademark a serial number of 87429782. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, December 9, 2024. This trademark is owned by Abbott Diabetes Care Inc.. The FREESTYLE LIBRE trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for diabetes management use; medical apparatus and instruments for monitoring interstitial fluid glucose; sensor-based glucose monitors for medical purposes; continuous glucose monitoring systems primarily composed of medical apparatus for monitoring interstitial fluid glucose
freestyle libre

General Information


Serial Number87429782
Word MarkFREESTYLE LIBRE
Filing DateFriday, April 28, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, December 9, 2024
Registration Number5531286
Registration DateTuesday, July 31, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 13, 2018

Trademark Statements


Translation of Words in MarkThe English translation of "LIBRE" in the mark is "FREE".
Goods and ServicesMedical apparatus and instruments for diabetes management use; medical apparatus and instruments for monitoring interstitial fluid glucose; sensor-based glucose monitors for medical purposes; continuous glucose monitoring systems primarily composed of medical apparatus for monitoring interstitial fluid glucose

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, May 4, 2017
Primary Code010
First Use Anywhere DateFriday, November 10, 2017
First Use In Commerce DateThursday, November 16, 2017

Trademark Owner History


Party NameAbbott Diabetes Care Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAlameda, CA 94502

Party NameAbbott Diabetes Care Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAlameda, CA 94502

Party NameAbbott Diabetes Care Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlameda, CA 94502

Trademark Events


Event DateEvent Description
Tuesday, August 1, 2017NON-FINAL ACTION WRITTEN
Tuesday, May 2, 2017NEW APPLICATION ENTERED
Thursday, May 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 26, 2017ASSIGNED TO EXAMINER
Thursday, February 1, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 1, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 1, 2017NON-FINAL ACTION E-MAILED
Thursday, February 1, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 2, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 31, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 8, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 9, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, May 9, 2018USE AMENDMENT FILED
Monday, November 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 1, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 26, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 27, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 31, 2018REGISTERED-PRINCIPAL REGISTER
Monday, July 31, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, June 12, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, December 9, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 9, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED